Trials
Search / Trial NCT05658822

Digestive Dysmotility in Mitochondrial Neurogastrointestinal Encephalomyopathy

Launched by HOSPITAL UNIVERSITARI VALL D'HEBRON RESEARCH INSTITUTE · Dec 17, 2022

Trial Information

Current as of January 17, 2025

Recruiting

Keywords

Intestinal Manometry Motility

ClinConnect Summary

This clinical trial is studying a rare condition called Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE), which affects how the digestive system works and can cause serious problems like nausea, severe stomach pain, and difficulty swallowing. The trial aims to better understand the specific issues in the digestive system that lead to these symptoms, as these can significantly impact the quality of life for those affected.

To participate in this trial, individuals must have a confirmed diagnosis of MNGIE, which is usually established through specific tests that look for certain genetic changes and enzyme activity. The trial is currently recruiting participants of all ages and genders. If you join the study, you can expect to undergo assessments to help researchers learn more about the condition and its effects on the body. This information is crucial for developing better treatments for MNGIE in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of MNGIE disease established by thymidine phosphorylase activity and mitochondrial mutation analysis.

About Hospital Universitari Vall D'hebron Research Institute

The Hospital Universitari Vall d'Hebron Research Institute (VHIR) is a leading biomedical research center affiliated with Vall d'Hebron University Hospital in Barcelona, Spain. Committed to advancing healthcare through innovative research, VHIR focuses on translating scientific discoveries into clinical applications, enhancing patient care and outcomes. The institute fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, emphasizing excellence in translational medicine, clinical trials, and public health initiatives. With a strong emphasis on ethical standards and patient safety, VHIR is dedicated to contributing to the global body of knowledge in various medical fields.

Locations

Barcelona, , Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials